Quadruple valve replacement in patients with carcinoid heart disease.
Arghami
Arman
A
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn 55905, USA.
Connolly
Heidi M
HM
Abel
Martin D
MD
Schaff
Hartzell V
HV
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002275:Carcinoid Heart Disease / Q000188:drug therapy / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide